drugset / Trial / NCT03208985

A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions

NCT03208985

Phase 3 Completed 1270 enrolled HRA Pharma
NaSingle-groupOpen-labelOther

Summary

This study is designed to assess whether consumers select and use ella® (ulipristal acetate 30mg), an emergency contraceptive, in a manner consistent with the OTC package directions in an OTC-like setting.

Timeline

Start
2017-05-23
Primary completion
2018-06-14
Completion
2018-06-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Ulipristal Acetate Unknown 30 mg

Indications

No indication recorded.